Trial intelligence / Profile preview

Preoperative Teriparatide for Lumbar Fusion Surgery

NCT03770338Active, not recruiting

Sponsor
The University of Hong Kong
Start
Mar 2019
Primary completion
Mar 2026
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

Randomised, double-blind trial of teriparatide in osteoporosis (2 arms), sponsored by The University of Hong Kong. Primary endpoint: Intraoperative insertional torque measurement. Started Mar 2019; status: active, not recruiting.

02

Drugs

teriparatide
03

Conditions

osteoporosis

Beyond the preview

Go deeper on NCT03770338.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03770338.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call